Literature DB >> 12064795

Chronic hepatitis C and autoimmune cholangitis: a case study and literature review.

Pilar Sánchez-Pobre1, Carmen Gonzalez, Estela Paz, Francisco Colina, Gregorio Castellano, Teresa Muñoz-Yague, Sarbelio Rodriguez, Carmen Yela, Victoria Alvarez, Ja Solís-Herruzo.   

Abstract

We present a case of a chronic hepatitis C with damage of bile ducts resembling primary biliary cirrhosis. The immunological profile (negative antimitochondrial antibodies and positive anti-nuclear antibody) was characteristic of the autoimmune cholangitis. One year of treatment with ursodeoxycholic acid returned the liver tests to the normal range but the liver lesions remained unchanged.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12064795     DOI： 10.1023/a:1015341625934

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  25 in total

1.  Granulomas and hepatitis C.

Authors:  R D Goldin; T S Levine; G R Foster; H C Thomas
Journal:  Histopathology       Date:  1996-03       Impact factor: 5.087

2.  Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?

Authors:  P Sánchez-Pobre; G Castellano; F Colina; P Dominguez; S Rodriguez; F Canga; J A Herruzo
Journal:  J Clin Gastroenterol       Date:  1996-10       Impact factor: 3.062

3.  Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity?

Authors:  S Sherlock
Journal:  Mayo Clin Proc       Date:  1998-02       Impact factor: 7.616

4.  Granulomatous cholangitis in chronic hepatitis C: a new diagnostic problem in liver pathology.

Authors:  M Hoso; Y Nakanuma; M Kawano; K Oda; K Tsuneyama; J van de Water; M E Gershwin
Journal:  Pathol Int       Date:  1996-04       Impact factor: 2.534

5.  [A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

Authors:  G Brunner; O Klinge
Journal:  Dtsch Med Wochenschr       Date:  1987-09-18       Impact factor: 0.628

6.  Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies.

Authors:  K Kaji; Y Nakanuma; M Sasaki; M Unoura; K Kobayashi; A Nonomura; K Tsuneyama; J Van de Water; M E Gershwin
Journal:  Mod Pathol       Date:  1994-12       Impact factor: 7.842

Review 7.  Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection.

Authors:  E D'Amico; M Paroli; V Fratelli; C Palazzi; V Barnaba; F Callea; G Consoli
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

8.  Epithelioid cell granulomas in chronic hepatitis C: immunohistochemical character and histological marker of favourable response to interferon-alpha therapy.

Authors:  K Harada; H Minato; K Hiramatsu; Y Nakanuma
Journal:  Histopathology       Date:  1998-09       Impact factor: 5.087

9.  Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group.

Authors:  J H Lefkowitch; E R Schiff; G L Davis; R P Perrillo; K Lindsay; H C Bodenheimer; L A Balart; T J Ortego; J Payne; J L Dienstag
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

Review 10.  Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.

Authors:  T Maeda; S Onishi; T Miura; S Iwamura; A Tomita; T Saibara; Y Yamamoto
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199
View more
  1 in total

Review 1.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.